Evaluation of Anti-Diabetic Activity of Silver Nanoparticles Synthesized from Ethanolic Extract of Phyllanthus niruri on Wistar Rats
Abstract
Diabetes is a metabolic disorder characterized by hyperglycemia resulting from either the deficiency in insulin secretion or the action of insulin Diabetes can affect numerous different organ systems in the body and, over time, can lead to serious complications. Complications are microvascular or macrovascular. To evaluate the anti-diabetic effect of Phyllanthus niruri silver nano-particles. Streptozotocin (STZ) of 50mg/kg is used to induce diabetes in wistar rats. The wistar rats were distributed to six different groups. Group-I represented as Control; Group-II represented as diabetic control (STZ ); Group-III represented as 5 mg/kg body weight of glibenclamide + diabetes; Group-IV represented as phyllanthus niruri extract + diabetes; Group-V represented as 100 µg Phyllanthus niruri silver nanoparticles + diabetes; group-6- Phyllanthus niruri silver nanoparticles150µg + diabetes. The silver nanoparticles were inspected for the morphological and optical properties investigated using UV spectrophotometer, SEM and FT-IR techniques. The AgNPs has shown characteristic peak at 428nm.The study revealed that the AgNPs treatment reduced serum blood glucose concentrations remarkable improvement in the body weight, Abnormal high serum levels in diabetes treatment with AgNp’s they reached to normal in STZ-challenged diabetic rats. The histo-pathological alterations were also studied in all the experimental animals. The pathology results revealed that the AgNPs treatment induces the regeneration of islets cells of pancreas in the experimental rats. The research study proved that the Phyllanthus niruri AgNPs exerts anti-diabetic properties.
Keywords: Diabetes, STZ, Phyllanthus niruri, silver nanoparticles
Keywords:
Diabetes, silver nanoparticles, phyllantus niruri, STZDOI
https://doi.org/10.22270/jddt.v13i6.6098References
Sami W, Ansari T, Butt NS, Hamid MRA. Effect of diet on type 2 diabetes mellitus: A review. Int J Health Sci (Qassim). 2017; 11(2):65-71.
Atkinson MA, Eisenbarth GS. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. The Lancet. 2001; 358(9277):221-229. https://doi.org/10.1016/S0140-6736(01)05415-0
Weyer C, Bogardus C, Mott DM, Pratley RE. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest. 1999 Sep; 104(6):787-94. https://doi.org/10.1172/JCI7231
Abutaleb MH. Diabetes mellitus: an overview. Pharm Pharmacol Int J. 2016; 4(5):406-11. https://doi.org/10.15406/ppij.2016.04.00087
Surampudi PN, John-Kalarickal J, Fonseca VA. Emerging concepts in the pathophysiology of type 2 diabetes mellitus. Mt Sinai J Med. 2009 Jun; 76(3):216-26. https://doi.org/10.1002/msj.20113
Nathan DM. Long-term complications of diabetes mellitus. New England journal of medicine. 1993 Jun 10; 328(23):1676-85. https://doi.org/10.1056/NEJM199306103282306
Krithiga N, Rajalakshmi A, Jayachitra A. Green synthesis of silver nanoparticles using leaf extracts of Clitoria ternatea and Solanum nigrum and study of its antibacterial effect against common nosocomial pathogens. Journal of Nanoscience. 2015; 2015:1-8. https://doi.org/10.1155/2015/928204
Ijaz I, Gilani E, Nazir A, Bukhari A. Detail review on chemical, physical and green synthesis, classification, characterizations and applications of nanoparticles. Green Chemistry Letters and Reviews. 2020 Jul 2; 13(3):223-45. https://doi.org/10.1080/17518253.2020.1802517
Pantidos N, Horsfall LE. Biological synthesis of metallic nanoparticles by bacteria, fungi and plants. Journal of Nanomedicine & Nanotechnology. 2014 Sep 1; 5(5):1.
Makarov VV, Love AJ, Sinitsyna OV, Makarova SS, Yaminsky IV, Taliansky ME, Kalinina NO. "Green" nanotechnologies: synthesis of metal nanoparticles using plants. Acta Naturae.
Elmer W, White JC. The future of nanotechnology in plant pathology. Annual review of phytopathology. 2018 Aug 25; 56:111-33. https://doi.org/10.1146/annurev-phyto-080417-050108
Srikar SK, Giri DD, Pal DB, Mishra PK, Upadhyay SN. Green synthesis of silver nanoparticles: a review. Green and Sustainable Chemistry. 2016 Feb 16; 6(1):34-56. https://doi.org/10.4236/gsc.2016.61004
Mediani A, Abas F, Maulidiani M, Khatib A, Tan CP, Ismail IS, Shaari K, Ismail A, Lajis NH. Metabolic and biochemical changes in streptozotocin induced obese-diabetic rats treated with Phyllanthus niruri extract. Journal of pharmaceutical and biomedical analysis. 2016 Sep 5; 128:302-12. https://doi.org/10.1016/j.jpba.2016.06.003
Al-Quraishy S, Dkhil MA, Moneim AE. Anti-hyperglycemic activity of selenium nanoparticles in streptozotocin-induced diabetic rats. International journal of nanomedicine. 2015; 10:6741. https://doi.org/10.2147/IJN.S91377
Vianna R, Brault A, Martineau LC, Couture R, Arnason JT, Haddad PS. In vivo anti-diabetic activity of the ethanolic crude extract of Sorbus decora CK Schneid.(Rosacea): a medicinal plant used by Canadian James Bay Cree nations to treat symptoms related to diabetes. Evidence-Based Complementary and Alternative Medicine. 2011 Jan 1; 2011. https://doi.org/10.1093/ecam/nep158
Kifle ZD, Enyew EF. Evaluation of in vivo antidiabetic, in vitro α-amylase inhibitory, and in vitro antioxidant activity of leaves crude extract and solvent fractions of Bersama abyssinica fresen (melianthaceae). Journal of Evidence-Based Integrative Medicine. 2020; 25:2515690X20935827. https://doi.org/10.1177/2515690X20935827
Kathireswari P, Gomathi S, Saminathan K. Plant leaf mediated synthesis of silver nanoparticles using Phyllanthus niruri and its antimicrobial activity against multi drug resistant human pathogens. Int J Curr Microbiol App Sci. 2014; 3:960-8.
Santhanam V, Durgadevi S, Abirami S. Effect of concentration, ph and time on the morphology of silver nanoparticles synthesized by green method using phyllanthus niruri and solanum nigrum leaf extracts. Int. J. Curr. Res. Rev. 2018 Nov; 10(21):25-9. https://doi.org/10.31782/IJCRR.2018.2529
Published
Abstract Display: 520 
PDF Downloads: 397 PDF Downloads: 63 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.